Commentary: SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
Serena Di Cosimo,
Luca Porcu,
Andrea Malfettone,
Javier Cortés,
Javier Cortés,
Javier Cortés,
Javier Cortés,
Javier Cortés,
Rosalba Miceli
Affiliations
Serena Di Cosimo
Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
Luca Porcu
Laboratory of Methodology for Clinical Research, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
Andrea Malfettone
Medica Scientia Innovation Research (MedSIR), New Jersey, United States
Javier Cortés
Medica Scientia Innovation Research (MedSIR), New Jersey, United States
Javier Cortés
Medica Scientia Innovation Research (MedSIR), Barcelona, Spain
Javier Cortés
IOB Institute of Oncology, Quiron Group, Madrid, Spain
Javier Cortés
IOB Institute of Oncology, Quiron Group, Barcelona, Spain
Javier Cortés
Vall d'Hebron Insititute of Oncology (VHIO), Barcelona, Spain
Rosalba Miceli
Clinical Epidemiology and Trial Organization Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
